<DOC>
	<DOCNO>NCT00785512</DOCNO>
	<brief_summary>This study evaluate long-term efficacy nebivolol monotherapy patient stage 1 stage 2 hypertension withdrawal active medication .</brief_summary>
	<brief_title>A Study Long-term Efficacy Nebivolol After Withdrawal Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>male female outpatient 18 79 year age Females must postmenopausal , pregnant use approved contraceptive regimen meet criterion stage I II hypertension currently treat , treat two antihypertensive medication type 1 type 2 diabetes secondary hypertension evidence concurrent disease condition might interfere conduct study treatment investigational study drug within 30 day Screening ( Visit 1 ) history hypersensitivity nebivolol βblockers</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>nebivolol</keyword>
	<keyword>Bystolic®</keyword>
	<keyword>Hypertension</keyword>
	<keyword>blood pressure</keyword>
	<keyword>withdrawal</keyword>
</DOC>